CNS Pharmaceuticals, Inc. (CNSP)
NASDAQ: CNSP · Real-Time Price · USD
2.890
-0.730 (-20.17%)
At close: Nov 13, 2026, 4:00 PM EST
3.100
+0.210 (7.27%)
After-hours: Nov 13, 2026, 4:10 PM EST
CNS Pharmaceuticals Market Cap
CNS Pharmaceuticals has a market cap or net worth of $4.22 million as of November 13, 2026. It is the 44,526th most valuable company in the world and the 5,888th biggest in the United States. Its market cap has increased by 11.54% in one year.
Market Cap
4.22M
Enterprise Value
-15.76M
1-Year Change
11.54%
Global Rank
Country Rank
#5,888 United States
Category
ChartMarket Cap Chart
Since November 8, 2019, CNS Pharmaceuticals's market cap has decreased from $69.92M to $4.22M, a decrease of -93.96%. That is a compound annual growth rate of -32.96%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 4.22M | 29.70% |
| Dec 31, 2025 | 3.26M | -52.95% |
| Dec 31, 2024 | 6.92M | 4.40% |
| Dec 29, 2023 | 6.63M | 109.26% |
| Dec 30, 2022 | 3.17M | -83.83% |
| Dec 31, 2021 | 19.60M | -51.07% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lantern Pharma | 6.15M |
| Processa Pharmaceuticals | 6.10M |
| Cerenome | 6.05M |
| Cardio Diagnostics Holdings | 5.72M |
| Addex Therapeutics | 5.67M |
| Aprea Therapeutics | 5.54M |
| XTL Biopharmaceuticals | 5.53M |
| Evogene | 5.48M |